| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.0058 | 1 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.0088 | 1 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0009 | 1 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.00097 | 1 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.0008 | 1 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | 0.0039 | 1 |